sales@businessmarketinsights.com     UK: +442081254005
   

US Dermatology OTC Medications Market Forecast to 2028 - COVID-19 Impact and Country Analysis By Product Type (Tablets and Capsules, Oils, Gels, Creams and Ointments, Others); Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Anti-Fungal, Wart Remover, Others); Route of Administration (Topical, Oral); Distribution Channel (Online Distribution, Hospital and Retail Pharmacies, Super and Hyper Markets)

Code: TIPRE00022065 | Pages: 140 | Industry: Pharmaceuticals | Date: Apr 2021
Covid

Market Introduction

Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin related diseases, such as pigmentation, acne, wrinkles, and psoriasis. OTC drugs are medications that are safe and effective for use by the public without seeking treatment by a health professional. The US dermatology OTC medications market growth is mainly attributed to rising prevalence of skin abnormalities and increasing availability of dermatology medication over the counter (OTC). Moreover, growing OTC market is further expected to foster the market growth during the forecast period. However, the side effects associated with OTC dermatology medication such as skin allergy, limit the growth of the market.

COVID-19 has affected a large population in the US leading to an unprecedented surge in demand for popular OTC drugs. Consumers appear to be trying to address illness symptoms on their own, to avoid doctor’s office. Physical distancing and stay-at-home orders have forced consumer to shop differently. Also, continuous use of mask and constant handwashing has led to skin irritation, and maskne. Constant handwashing has led to increase in conditions like skin dryness and eczema, this has led to increase in demand for dermatology OTC products.

Market Overview and Dynamics

The US dermatology OTC medications market is projected to reach US$ 1,124.56 million by 2028 from US$ 952.97 million in 2020. The market is anticipated to grow with a CAGR of 2.1% from 2021 to 2028. Factors driving the market growth are rising prevalence of skin abnormalities and increasing availability of dermatology medication over the counter (OTC). However, side effects associated with OTC dermatology medication such as skin allergy are likely to have a negative impact on the market growth.

Key Market Segments

Based on product type, the creams and ointments segment accounted for the largest share of the US dermatology OTC medications market in 2020. In terms of indication, the dermatitis segment held the largest share of the dermatology OTC medications market in the US. Based on route of administration, the topical segment held a larger share of the dermatology OTC medications market in the US. Based on distribution channel, the hospital and retail pharmacies segment held the largest share of the market.

Major Sources

A few major primary and secondary sources referred to while preparing the US dermatology OTC medications market report are World Health Organization, and Centre for Disease Prevention and Control.

Reasons to buy the report

  • To understand the US dermatology OTC medications market landscape and identify market segments that are most likely to guarantee a strong return
  • To stay ahead in comprehending the ever-changing competitive landscape of the US dermatology OTC medications market
  • To efficiently plan M&A and partnership deals in the US dermatology OTC medications market by identifying market segments with the most promising probable sales
  • To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the US dermatology OTC medications market
  • To obtain market revenue forecast from 2021 to 2028 in various segments of the US dermatology OTC medications

US DERMATOLOGY OTC MEDICATIONSMARKET SEGMENTATION

By Product Type

  • Tablets and Capsules
  • Oils
  • Gels
  • Creams and Ointments
  • Others

 

By Indication

  • Dermatitis
  • Acne
  • Psoriasis
  • Skin Bleaching
  • Anti-Fungal
  • Wart Remover
  • Others

By Route of Administration

  • Topical
  • Oral

 

By Distribution Channel

  • Online Distribution
  • Hospital and Retail Pharmacies
  • Super and Hyper Markets

 

Company Profiles

  • Bausch Health Companies Inc
  • Perrigo Company Plc
  • Bayer AG
  • Viatris Inc.
  • Johnson and Johnson Services, Inc.
  • LEO Pharma A/S
  • GlaxoSmithKline Plc.
  • Galderma
  • Dr. Reddy's Laboratories
  • Acella Pharmaceuticals, LLC

1.          Introduction

1.1        Study Scope

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        US Dermatology OTC Medications Market – By Product Type

1.3.2        US Dermatology OTC Medications Market – By Indication

1.3.3        US Dermatology OTC Medications Market – By Route of Administration

1.3.4        US Dermatology OTC Medications Market – By Distribution Channel

2.          Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          US Dermatology OTC Medications Market Landscape

4.1        Market Overview

4.2        PEST Analysis

4.2.1        US: PEST Analysis

4.3        Expert Opinion

5.          US Dermatology OTC Medications Market – Key Market Dynamics

5.1        Market Drivers

5.1.1        Rising Prevalence of Skin Abnormalities

5.1.2        Increasing Availability of Dermatology Medication Over the Counter (OTC)

5.2        Market Restraints

5.2.1        Side Effects Associated with OTC Dermatology Medication

5.3        Market Opportunities

5.3.1        Growing OTC Market

5.4        Future Trends

5.4.1        Rising Adoption of Telemedicine

5.5        Impact Analysis

6.          Dermatology OTC Medications– US Market Analysis

6.1        US Dermatology OTC Medications Market Overview

6.2        Market Positioning of Key Players

7.          US Dermatology OTC Medications Market Analysis– Product Type

7.1        Overview

7.2        US Dermatology OTC Medications Market, by Product Type 2020 & 2028 (%)

7.3        Tablets and Capsules

7.3.1        Overview

7.3.2        US Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ Mn)

7.4        Oils

7.4.1        Overview

7.4.2        US Oils Market Revenue and Forecasts to 2028 (US$ Mn)

7.5        Gels

7.5.1        Overview

7.5.2        US Gels Market Revenue and Forecasts to 2028 (US$ Mn)

7.6        Creams and Ointments

7.6.1        Overview

7.6.2        Creams and Ointments Market Revenue and Forecasts to 2028 (US$ Mn)

7.7        Others

7.7.1        Overview

7.7.2        Others Market Revenue and Forecasts to 2028 (US$ Mn)

8.          US Dermatology OTC Medications Market Analysis – Indication

8.1        Overview

8.2        US Dermatology OTC Medications Market, By Indication 2020 & 2028 (%)

8.3        Dermatitis

8.3.1        Overview

8.3.2        US Dermatitis Market Revenue and Forecasts to 2028 (US$ Mn)

8.4        Acne

8.4.1        Overview

8.4.2        US Acne Market Revenue and Forecasts to 2028 (US$ Mn)

8.5        Psoriasis

8.5.1        Overview

8.5.2        US Psoriasis Market Revenue and Forecasts to 2028 (US$ Mn)

8.6        Skin Bleaching

8.6.1        Overview

8.6.2        US Skin Bleaching Market Revenue and Forecasts to 2028 (US$ Mn)

8.7        Anti-Fungal

8.7.1        Overview

8.7.2        US Anti-Fungal Market Revenue and Forecasts to 2028 (US$ Mn)

8.8        Wart Remover

8.8.1        Overview

8.8.2        US Wart Remover Market Revenue and Forecasts to 2028 (US$ Mn)

8.9        Others

8.9.1        Overview

8.9.2        US Others Market Revenue and Forecasts to 2028 (US$ Mn)

9.          US Dermatology OTC Medications Market Analysis – Route of Administration

9.1        Overview

9.2        US Dermatology OTC Medications Market, By Route of Administration 2020 & 2028 (%)

9.3        Topical

9.3.1        Overview

9.3.2        US Topical Market Revenue and Forecasts to 2028 (US$ Mn)

9.4        Oral

9.4.1        Overview

9.4.2        US Oral Market Revenue and Forecasts to 2028 (US$ Mn)

10.       US Dermatology OTC Medications Market Analysis – Distribution Channel

10.1      Overview

10.2      US Dermatology OTC Medications Market, By Distribution Channel 2020 & 2028 (%)

10.3      Online Distribution

10.3.1     Overview

10.3.2     US Online Distribution Market Revenue and Forecasts to 2028 (US$ Mn)

10.4      Hospital and Retail Pharmacies

10.4.1     Overview

10.4.2     US Hospital and Retail Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

10.5      Super and Hyper Markets

10.5.1     Overview

10.5.2     US Super and Hyper Markets Market Revenue and Forecasts to 2028 (US$ Mn)

11.       Impact of COVID-19 Pandemic on US Dermatology OTC Medications Market

11.1      US: Impact Assessment of COVID-19 Pandemic

12.       US OTC Dermatology Medications Market– Industry Landscape

12.1      Overview

13.       Company Profiles

13.1      Bausch Health Companies Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Perrigo Company plc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bayer AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Viatris Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      LEO Pharma A/S

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      GlaxoSmithKline plc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Galderma

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Dr. Reddy's Laboratories

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   ACELLA PHARMACEUTICALS, LLC

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.       Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

LIST OF TABLES

Table 1.            Inorganic Developments Done by Companies

Table 2.            Glossary of Terms, US OTC Dermatology Medications Market


LIST OF FIGURES

Figure 1.           US Dermatology OTC Medications Market Segmentation

Figure 2.           US Dermatology OTC Medications Market Overview

Figure 3.           Creams and Ointments Segment by Product Type is Expected to Show Remarkable Growth During Forecast Period

Figure 4.           US: PEST Analysis

Figure 5.           Expert Opinion

Figure 6.           US Dermatology OTC Medications Market Impact Analysis of Drivers and Restraints

Figure 7.           Overview of US Dermatology OTC Medications Market

Figure 8.           Market Positioning of Key Players in US Dermatology OTC Medications Market

Figure 9.           US Dermatology OTC Medications Market, By Product Type 2020 & 2028 (%)

Figure 10.        US Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        US Oils Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        US Gels Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        US Creams and Ointments Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        US Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        US Dermatology OTC Medications Market, by Indication 2020 & 2028 (%)

Figure 16.        US Dermatitis Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        US Acne Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        US Psoriasis Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        US Skin Bleaching Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        US Anti-Fungal Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        US Wart Remover Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        US Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23.        US Dermatology OTC Medications Market, by Route of Administration 2020 & 2028 (%)

Figure 24.        US Topical Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        US Oral Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26.        US Dermatology OTC Medications Market, by Distribution Channel 2020 & 2028 (%)

Figure 27.        US Online Distribution Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        US Hospital and Retail Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        US Super and Hyper Markets Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30.        Impact of COVID-19 Pandemic on OTC Dermatology Medications in the US

The List of Companies - US Dermatology OTC Medications Market

  1. Bausch Health Companies Inc
  2. Perrigo Company Plc
  3. Bayer AG
  4. Viatris Inc.
  5. Johnson and Johnson Services, Inc.
  6. LEO Pharma A/S
  7. GlaxoSmithKline Plc.
  8. Galderma
  9. Dr. Reddy's Laboratories
  10. Acella Pharmaceuticals, LLC
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US dermatology OTC medications market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global US dermatology OTC medications market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Related Tags US Dermatology OTC Medications Market US Dermatology OTC Medications Market Research US Dermatology OTC Medications Market Insight US Dermatology OTC Medications Market Trends US Dermatology OTC Medications Market Forecast US Dermatology OTC Medications Market Share US Dermatology OTC Medications Market 2028 US Dermatology OTC Medications Market Growth US Dermatology OTC Medications Industry Sector US Dermatology OTC Medications PDF Report US Dermatology OTC Medications Analysis US Dermatology OTC Medications Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000